Antiretroviral Therapy
Antiretroviral CSF penetration improves cognitive disorders in HIV infection
Published in AIDS Weekly, November 22nd, 2004
According to recent research from the United States, "The benefits of combination antiretroviral therapy (ART) for HIV cognitive disorders vary substantially between individuals. This study evaluated whether cerebrospinal fluid (CSF) drug penetration and CSF virological suppression influence the extent of neuropsychological (NP) improvement during ART."
"Overall performance on a battery of NP tests administered at baseline and follow-up (median 15 weeks) was computed by using the global deficit score (GDS) methods in 31 cognitively impaired,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-11-22)
More Articles from AIDS Weekly
- HIV/AIDS Perinatal Transmission
Nevirapine does not prevent perinatal HIV-1 transmission in the field - HIV/AIDS Risk
Adolescent woman may be more susceptible to HIV infection than men in Cameroon - HIV/AIDS Therapy
HIV viral load after 4 weeks of HAART predicts virologic outcome at 24 weeks - JC Virus
PMA and IL-1beta dramatically increase JC virus transcription in glial cells - AIDS/HIV Diagnosis
OraQuick ADVANCE rapid HIV-1/2 antibody test is sensitive and specific - AIDS/HIV Vaccine
DNA vaccine elicits efficient CD8+ T cell response to HIV epitope - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
